Durata Therapeutics

Fougera Pharmaceuticals, Inc.

Acquired by Actavis

Developed dalbavancin, an antibiotic active against gram-positive bacteria. Spun-out of Pfizer. Now an approved drug.

Chicago, IL
NASDAQ: DRTX

Submit a Comment